The dilutive private placement at a ~$5M market cap signals acute cash needs and is a strong negative signal. Monitor for further cash burn and potential Nasdaq compliance issues given the small market cap. The 180-day lock-up by insiders provides some near-term support, but the overhang from the upcoming resale registration is significant.
Price Chart
Executive Summary
Biomerica entered into a securities purchase agreement on August 20, 2026, to sell 1,393,705 shares at $1.60/share for ~$2.23M gross proceeds in a private placement to institutional and individual investors, including B. Riley Principal Capital and certain directors/officers. The company also granted registration rights and B. Riley gets a board seat if it holds ≥10% voting power. This dilutive capital raise, at a $5M market cap, signals acute cash needs and is a clear negative for existing shareholders, outweighing any governance provisions.
Key Financial Metrics
Key Facts
- Biomerica sold 1,393,705 shares at $1.60/share for ~$2.23M gross proceeds in a private placement.
- Purchasers include B. Riley Principal Capital and certain directors/executive officers.
- B. Riley gets the right to designate a board member if it holds ≥10% voting power.
- Directors and executive officers are subject to a 180-day lock-up.
- The company must file a resale registration statement within 30 days of closing (Aug 26, 2026).
- Market cap is ~$5M; the offering represents ~45% dilution based on implied pre-offering shares.
Financial Impact
~$2.23M gross proceeds from sale of 1,393,705 shares at $1.60/share, representing ~45% dilution to existing shareholders given a ~$5M market cap.
Risk Factors
- Significant dilution (~45%) to existing shareholders.
- Potential for further capital raises given the small market cap and cash needs.
- Nasdaq listing compliance risk if the stock price continues to decline.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040251 |
| Document: 0001493152-26-040251-index.html | 0001493152-26-040251 |
| Document: 0001493152-26-040251.txt | 0001493152-26-040251 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | DEF 14A | $1.76 | awaiting T+20 | — | $1.69 (−3.98%) |
Oct 15, 2026 10d ago | 8-K | $1.85 | awaiting T+20 | — | $1.69 (−8.65%) |
Oct 8, 2026 18d ago | EFFECT | $1.89 | awaiting T+20 | — | $1.69 (−10.58%) |
Oct 8, 2026 18d ago | EFFECT | $1.89 | awaiting T+20 | — | $1.69 (−10.58%) |
Sep 25, 2026 4w ago | S-3 | $2.32 $1.68 | ▲ +27.59% | ▲ +26.11% | $1.69 (+27.16%) |
Sep 24, 2026 4w ago | S-3 | $2.32 $1.68 | ▲ +27.59% | ▲ +26.11% | $1.69 (+27.16%) |
Sep 1, 2026 7w ago | Press Release | $2.09 $2.26 | ▲ +8.13% | ▲ +7.82% | $1.69 (−19.14%) |
Aug 27, 2026 8w ago | Insider Cluster | $2.14 $2.39 | ▲ +11.68% | ▲ +12.16% | $1.69 (−21.03%) |
Aug 26, 2026 8w ago | 8-K | $2.10 $2.40 | ▼ −14.29% | ▼ −14.39% | $1.69 (+19.52%) |
Jun 4, 2026 20w ago | 8-K | $2.12 $1.73 | ▼ −18.40% | ▼ −20.26% | $1.69 (−20.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers